Jesús Molpeceres García del Pozo-rekin lankidetzan egindako argitalpenak (18)

2002

  1. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres

    Journal of Microencapsulation, Vol. 19, Núm. 1, pp. 61-72

2001

  1. Cyclosporine-loaded polycaprolactone nanoparticles: Immunosuppression and nephrotoxicity in rats

    European Journal of Pharmaceutical Sciences, Vol. 12, Núm. 4, pp. 471-478

  2. Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats

    Pharmazie, Vol. 56, Núm. 1, pp. 78-82

2000

  1. Biodegrable nanoparticles as a delivery system for cyclosporine: Preparation and characterization

    Journal of Microencapsulation, Vol. 17, Núm. 5, pp. 599-614

  2. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose

    International Journal of Pharmaceutics, Vol. 197, Núm. 1-2, pp. 129-141

  3. Effect of nanoparticles on digitoxin uptake and pharmacologic activity in rat glomerular mesangial cell cultures

    Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, Vol. 7, Núm. 4, pp. 215-222

  4. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Núm. 3, pp. 379-387

1999

  1. A polycaprolactone nanoparticle formulation of cyclosporin-a improves the prediction of area under the curve using a limited sampling strategy

    International Journal of Pharmaceutics, Vol. 187, Núm. 1, pp. 101-113

  2. Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers

    European Journal of Pharmaceutical Sciences, Vol. 8, Núm. 2, pp. 99-107

1998

  1. Age and sex dependent pharmacokinetics of cyclosporine in the rat after a single intravenous dose

    International Journal of Pharmaceutics, Vol. 174, Núm. 1-2, pp. 9-18

  2. Nuevas formas de administracion del interferon

    Farmacia Clinica

1997

  1. Stability of cyclosporine-loaded poly-Σ-caprolactone nanoparticles

    Journal of Microencapsulation, Vol. 14, Núm. 6, pp. 777-787

1996

  1. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement

    Journal of Pharmaceutical Sciences, Vol. 85, Núm. 2, pp. 206-213

  2. Exothermic-endothermic heat of solution shift of cyclosporin A related to poloxamer 188 behavior in aqueous solutions

    International Journal of Pharmaceutics, Vol. 130, Núm. 1, pp. 75-81

  3. Optimized preparation of poly D,L (lactic-glycolic) microspheres and nanoparticles for oral administration

    International Journal of Pharmaceutics, Vol. 141, Núm. 1-2, pp. 81-91

  4. Preparation, characterization and in vitro drug release of poly-ε-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres

    Journal of Microencapsulation, Vol. 13, Núm. 1, pp. 25-39

1994

  1. Gelatine gels and polyoxyethylene-polyoxypropylene gels: Comparative study of their properties

    Drug Development and Industrial Pharmacy, Vol. 20, Núm. 12, pp. 2041-2048

1992

  1. Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration

    International Journal of Pharmaceutics, Vol. 80, Núm. 1-3, pp. 119-127